Injectable calcium phosphate cement and fibrin sealant recombined human bone morphogenetic protein-2 composite in vertebroplasty: an animal study
Polymethylmethacrylate (PMMA) is currently the most commonly-used material, but it may induce adjacent vertebral fracture due to low degradation and high strength. Our study evaluated the feasibility of injectable calcium phosphate cement (ICPC) and fibrin sealant (FS) as an injectable compound car...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Association of Basic Medical Sciences of Federation of Bosnia and Herzegovina
2012-11-01
|
| Series: | Biomolecules & Biomedicine |
| Subjects: | |
| Online Access: | https://www.bjbms.org/ojs/index.php/bjbms/article/view/2443 |
| _version_ | 1797260878478835712 |
|---|---|
| author | Guang Qian Youhai Dong Wencheng Yang Minghai Wang |
| author_facet | Guang Qian Youhai Dong Wencheng Yang Minghai Wang |
| author_sort | Guang Qian |
| collection | DOAJ |
| description |
Polymethylmethacrylate (PMMA) is currently the most commonly-used material, but it may induce adjacent vertebral fracture due to low degradation and high strength. Our study evaluated the feasibility of injectable calcium phosphate cement (ICPC) and fibrin sealant (FS) as an injectable compound carrier of human bone morphogenetic protein-2 (rhBMP-2) in New Zealand rabbits for vertebroplasty. Results showed ICPC/FS/rhBMP-2 composites induced alkaline phosphatase most effectively at 2 and 4 weeks after implantation. Histological examination confirmed that new bone and vessels developed at 4 weeks in the ICPC/FS/rhBMP-2 group. At 8 weeks, parts of the ICPC/FS/rhBMP-2 cement degraded with mature bone tissues and neovascularization. New bone was observed by MicroCT to form early and massively, and the ossification was almost synchronous with the material degradation. In the PMMA Group, however, no new bone formation or material degradation was found. The stiffness and tension of vertebral bodies implanted with ICPC/FS/rhBMP-2 were weaker than those of normal vertebral bodies as well as vertebral bodies implanted with PMMA at 4 weeks (p<0.05). At 8 weeks, the stiffness and tension of vertebral bodies implanted with ICPC/FS/rhBMP-2 became strong; no significant difference was noted in the stiffness and tension, compared with normal vertebral bodies (p>0.05), while they were significantly lower, compared with vertebral bodies implanted with PMMA (p<0.05). It is concluded that, with good characteristics of osteoinductivity, the bone substitution is synchronous with material degradation.
|
| first_indexed | 2024-04-24T23:32:19Z |
| format | Article |
| id | doaj.art-4aadcdb87c81411bb57bade9e8053fde |
| institution | Directory Open Access Journal |
| issn | 2831-0896 2831-090X |
| language | English |
| last_indexed | 2024-04-24T23:32:19Z |
| publishDate | 2012-11-01 |
| publisher | Association of Basic Medical Sciences of Federation of Bosnia and Herzegovina |
| record_format | Article |
| series | Biomolecules & Biomedicine |
| spelling | doaj.art-4aadcdb87c81411bb57bade9e8053fde2024-03-15T14:33:55ZengAssociation of Basic Medical Sciences of Federation of Bosnia and HerzegovinaBiomolecules & Biomedicine2831-08962831-090X2012-11-0112410.17305/bjbms.2012.2443263Injectable calcium phosphate cement and fibrin sealant recombined human bone morphogenetic protein-2 composite in vertebroplasty: an animal studyGuang Qian0Youhai Dong1Wencheng Yang2Minghai Wang3Department of Orthopedics, The Fifth Hospital of Shanghai, Fudan UniversityDepartment of Orthopedics, The Fifth Hospital of Shanghai, Fudan UniversityDepartment of Orthopedics, The Fifth Hospital of Shanghai, Fudan UniversityDepartment of Orthopedics, The Fifth Hospital of Shanghai, Fudan University Polymethylmethacrylate (PMMA) is currently the most commonly-used material, but it may induce adjacent vertebral fracture due to low degradation and high strength. Our study evaluated the feasibility of injectable calcium phosphate cement (ICPC) and fibrin sealant (FS) as an injectable compound carrier of human bone morphogenetic protein-2 (rhBMP-2) in New Zealand rabbits for vertebroplasty. Results showed ICPC/FS/rhBMP-2 composites induced alkaline phosphatase most effectively at 2 and 4 weeks after implantation. Histological examination confirmed that new bone and vessels developed at 4 weeks in the ICPC/FS/rhBMP-2 group. At 8 weeks, parts of the ICPC/FS/rhBMP-2 cement degraded with mature bone tissues and neovascularization. New bone was observed by MicroCT to form early and massively, and the ossification was almost synchronous with the material degradation. In the PMMA Group, however, no new bone formation or material degradation was found. The stiffness and tension of vertebral bodies implanted with ICPC/FS/rhBMP-2 were weaker than those of normal vertebral bodies as well as vertebral bodies implanted with PMMA at 4 weeks (p<0.05). At 8 weeks, the stiffness and tension of vertebral bodies implanted with ICPC/FS/rhBMP-2 became strong; no significant difference was noted in the stiffness and tension, compared with normal vertebral bodies (p>0.05), while they were significantly lower, compared with vertebral bodies implanted with PMMA (p<0.05). It is concluded that, with good characteristics of osteoinductivity, the bone substitution is synchronous with material degradation. https://www.bjbms.org/ojs/index.php/bjbms/article/view/2443polymethylmethacrylatecalcium phosphatesbone morphogenetic proteinshistologyvertebroplasty |
| spellingShingle | Guang Qian Youhai Dong Wencheng Yang Minghai Wang Injectable calcium phosphate cement and fibrin sealant recombined human bone morphogenetic protein-2 composite in vertebroplasty: an animal study Biomolecules & Biomedicine polymethylmethacrylate calcium phosphates bone morphogenetic proteins histology vertebroplasty |
| title | Injectable calcium phosphate cement and fibrin sealant recombined human bone morphogenetic protein-2 composite in vertebroplasty: an animal study |
| title_full | Injectable calcium phosphate cement and fibrin sealant recombined human bone morphogenetic protein-2 composite in vertebroplasty: an animal study |
| title_fullStr | Injectable calcium phosphate cement and fibrin sealant recombined human bone morphogenetic protein-2 composite in vertebroplasty: an animal study |
| title_full_unstemmed | Injectable calcium phosphate cement and fibrin sealant recombined human bone morphogenetic protein-2 composite in vertebroplasty: an animal study |
| title_short | Injectable calcium phosphate cement and fibrin sealant recombined human bone morphogenetic protein-2 composite in vertebroplasty: an animal study |
| title_sort | injectable calcium phosphate cement and fibrin sealant recombined human bone morphogenetic protein 2 composite in vertebroplasty an animal study |
| topic | polymethylmethacrylate calcium phosphates bone morphogenetic proteins histology vertebroplasty |
| url | https://www.bjbms.org/ojs/index.php/bjbms/article/view/2443 |
| work_keys_str_mv | AT guangqian injectablecalciumphosphatecementandfibrinsealantrecombinedhumanbonemorphogeneticprotein2compositeinvertebroplastyananimalstudy AT youhaidong injectablecalciumphosphatecementandfibrinsealantrecombinedhumanbonemorphogeneticprotein2compositeinvertebroplastyananimalstudy AT wenchengyang injectablecalciumphosphatecementandfibrinsealantrecombinedhumanbonemorphogeneticprotein2compositeinvertebroplastyananimalstudy AT minghaiwang injectablecalciumphosphatecementandfibrinsealantrecombinedhumanbonemorphogeneticprotein2compositeinvertebroplastyananimalstudy |